Aflibercept - PDFSEARCH.IO - Document Search Engine

Aflibercept
Results: 25

#	Item
11	7.1 AFLIBERCEPT 4 mg/0.1 mL injection, 1 x 0.1 mL vial, 4 mg/0.1 mL injection, 1 x 0.09 mL syringe; Eylea®; Bayer Australia Ltd. Add to Reading List Source URL: www.pbs.gov.au Language: English - Date: 2015-03-16 01:05:14 Ranibizumab Bevacizumab Vascular endothelial growth factor Macular degeneration Macular edema Pharmaceutical Benefits Scheme Central retinal vein occlusion Off-label use Macula of retina Medicine Ophthalmology Health
12	Public Summary Document – November 2014 PBAC Meeting 6.2 AFLIBERCEPT 4 mg/0.1 mL injection, 1 x 0.1 mL vial, Add to Reading List Source URL: www.pbs.gov.au Language: English - Date: 2015-03-16 01:05:14 Ranibizumab Vascular endothelial growth factor Bevacizumab Macular degeneration Macular edema Diabetic retinopathy Laser coagulation Off-label use Retina Medicine Ophthalmology Health
13	Advances in the Treatment of Colorectal Cancer University of Colorado Gastrointestinal Malignancies Program November 2, 2013 Add to Reading List Source URL: www.ucdenver.edu Language: English - Date: 2013-11-01 12:26:15 Gastrointestinal cancer Bevacizumab Colorectal cancer Cetuximab Panitumumab KRAS Oxaliplatin Fluorouracil Aflibercept Medicine Chemistry Pharmacology
14	Public Summary Document Application No. 1310 – Optical coherence tomography to inform treatment with aflibercept Sponsor/Applicant/s: Add to Reading List Source URL: www.msac.gov.au Language: English - Date: 2014-11-06 23:49:50 Blindness Macular edema Diabetic retinopathy Glaucoma Ranibizumab Vascular endothelial growth factor Central retinal vein occlusion Macular degeneration Macula of retina Ophthalmology Vision Medicine
15	Public Summary Document Application No. 1310 – Optical coherence tomography to inform treatment with aflibercept Add to Reading List Source URL: www.msac.gov.au Language: English - Date: 2014-11-06 23:49:51 Blindness Macular edema Ranibizumab Glaucoma Macular degeneration Central retinal vein occlusion Vascular endothelial growth factor Diabetic retinopathy Macula of retina Ophthalmology Vision Medicine
16	NATIONAL CANCER DRUG FUND PRIORITISATION SCORES Drug Indication AFLIBERCEPT Add to Reading List Source URL: www.england.nhs.uk Language: English - Date: 2013-10-01 10:44:56 Quality of life End point of clinical trials Cetuximab Chemistry Medicine Oxaliplatin
17	Diagnosis and Management of Metastatic Colorectal Cancer: State-of-the-Art Oncology Nursing Practice (Includes NCCN[removed]Guideline Update) Add to Reading List Source URL: www.oncolink.org Language: English - Date: 2014-09-30 11:06:15 Bevacizumab Cetuximab Gastrointestinal cancer Colorectal cancer Capecitabine National Comprehensive Cancer Network Oxaliplatin Aflibercept Medicine Chemistry Pharmacology
18	BLA[removed]Page 4 HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use EYLEA safely and effectively. See full prescribing information for EYLEA. EYLEA® (aflibercept) Add to Reading List Source URL: www.accessdata.fda.gov Language: English - Date: 2014-10-08 11:03:00 Ranibizumab Vascular endothelial growth factor Macular edema Diabetic retinopathy Central retinal vein occlusion Ketorolac Endophthalmitis Retina Macular degeneration Ophthalmology Medicine Health
19	Aflibercept FLT1 Bevacizumab soluble Add to Reading List Source URL: www.pharmgkb.org - Date: 2014-12-01 18:17:56
20	HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ZALTRAP safely and effectively. See full prescribing information for ZALTRAP. ZALTRAP® (ziv-aflibercept) Injection Add to Reading List Source URL: www.accessdata.fda.gov Language: English - Date: 2012-08-03 13:42:37 Pfizer Irinotecan Lactams Lactones Piperidines FOLFIRI Adverse effect Pharmacology Medicine Prodrugs Health

UPDATE